News Image

Moleculin Reports Second Quarter 2025 Financial Results and Highlights

Provided By GlobeNewswire

Last update: Aug 13, 2025

- Continues recruitment and opens US and EU sites for the Phase 2B/3 MIRACLE trial

- 20+ additional clinical sites in Europe and the US expected to begin recruitment by the end of Q3

Read more at globenewswire.com

MOLECULIN BIOTECH INC

NASDAQ:MBRX (11/6/2025, 8:00:01 PM)

After market: 0.45 -0.01 (-1.42%)

0.4565

-0.02 (-4.24%)



Find more stocks in the Stock Screener

Follow ChartMill for more